Allstate Corporation’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$935K Sell
17,193
-13,634
-44% -$664K 0.01% 777
2026
Q1
$1.32M Buy
+30,827
New +$1.33M 0.01% 698
2019
Q3
Sell
-45,680
Closed -$976K 502
2019
Q2
$976K Buy
+45,680
New +$957K 0.02% 389

Other funds holding EXEL

Allstate Corporation's EXEL Position: Q2 2026 in Review

Allstate Corporation reduced its Exelixis (EXEL) stake by 44% in Q2 2026, selling an estimated $664K and leaving 17,193 shares worth $935K. The position accounts for 0.01% of the portfolio, ranked #777.

Allstate Corporation first reported a position in EXEL in Q2 2019 and has held it in 3 quarters since. The position peaked at $1.32M in Q1 2026. 760 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • Allstate Corporation held 17,193 shares of Exelixis worth $935K as of Q2 2026.
  • Allstate Corporation sold 13,634 Exelixis shares in Q2 2026, an estimated $664K.
  • Exelixis made up 0.01% of Allstate Corporation's portfolio in Q2 2026, its #777 holding.
  • Allstate Corporation first reported a position in Exelixis in Q2 2019 and has held it in 3 quarters since.
  • Allstate Corporation's Exelixis position peaked at $1.32M in Q1 2026.
  • 760 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on Allstate Corporation's 13F filing for Q2 2026, filed 13 Aug 2026.